Accuracy of New John Cunningham Virus Antibody Assay in Natalizumab-Treated Patients With Multiple Sclerosis

被引:3
作者
Gelissen, Liza M. Y. [1 ]
Wijburg, Martijn T. [1 ]
Strijbis, Eva M. M. [1 ]
van Oosten, Bob W. [1 ]
de Jong, Brigit A. [1 ]
Uitdehaag, Bernard M. J. [1 ]
Rispens, Theo [2 ,3 ]
Feltkamp, Mariet C. W. [2 ,4 ]
van Kempen, Zoe L. E. [1 ]
Killestein, Joep [1 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr UMC Locat Boelelaan, MS Ctr Amsterdam, Neurol,Amsterdam Neurosci, Amsterdam, Netherlands
[2] Sanquin Blood Supply, Res & Lab Serv Dept, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Amsterdam UMC, Amsterdam, Netherlands
[4] Leiden Univ, Dept Med Microbiol & Infect Prevent, Med Ctr, Leiden, Netherlands
关键词
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK;
D O I
10.1001/jamaneurol.2025.0337
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:523 / 525
页数:3
相关论文
共 50 条
[31]   Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab [J].
Sgarlata, Eleonora ;
Chisari, Clara Grazia ;
D'Amico, Emanuele ;
Millefiorini, Enrico ;
Patti, Francesco .
CNS DRUGS, 2020, 34 (05) :535-543
[32]   Sequencing and Analysis of JC Virus DNA From Natalizumab-Treated PML Patients [J].
Reid, Carl E. ;
Li, Huo ;
Sur, Gargi ;
Carmillo, Paul ;
Bushnell, Steven ;
Tizard, Rich ;
McAuliffe, Michele ;
Tonkin, Christopher ;
Simon, Kenneth ;
Goelz, Susan ;
Cinque, Paola ;
Gorelik, Leonid ;
Carulli, John P. .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (02) :237-244
[33]   Assessment of JC Virus DNA in Blood and Urine from Natalizumab-Treated Patients [J].
Rudick, Richard A. ;
O'Connor, Paul W. ;
Polman, Chris H. ;
Goodman, Andrew D. ;
Ray, Soma S. ;
Griffith, Nancy M. ;
Jurgensen, Stephanie A. ;
Gorelik, Leonid ;
Forrestal, Fiona ;
Sandrock, Alfred W. ;
Goelz, Susan E. .
ANNALS OF NEUROLOGY, 2010, 68 (03) :304-310
[34]   Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns [J].
Major, Eugene O. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11) :1041-1043
[35]   JCV detection in multiple sclerosis patients treated with natalizumab [J].
Sadiq, Saud A. ;
Puccio, Lauren M. ;
Brydon, Edward W. A. .
JOURNAL OF NEUROLOGY, 2010, 257 (06) :954-958
[36]   JCV detection in multiple sclerosis patients treated with natalizumab [J].
Saud A. Sadiq ;
Lauren M. Puccio ;
Edward W. A. Brydon .
Journal of Neurology, 2010, 257 :954-958
[37]   Assay Design and Sample Collection Can Affect Anti-John Cunningham Virus Antibody Detection [J].
Goelz, Susan E. ;
Gorelik, Leonid ;
Subramanyam, Meena .
ANNALS OF NEUROLOGY, 2011, 69 (02) :429-430
[38]   Proposed MRI Safety Monitoring of Patients with Multiple Sclerosis Treated with Natalizumab [J].
Vaneckova, M. ;
Seidl, Z. .
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2016, 79 (06) :663-669
[39]   JC-virus seroconversion in multiple sclerosis patients receiving natalizumab [J].
Outteryck, Olivier ;
Zephir, Helene ;
Salleron, Julia ;
Ongagna, Jean-Claude ;
Etxeberria, Ana ;
Collongues, Nicolas ;
Lacour, Arnaud ;
Fleury, Marie-Celine ;
Blanc, Frederic ;
Giroux, Marianne ;
de Seze, Jerome ;
Vermersch, Patrick .
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) :822-829
[40]   John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis [J].
Kapica-Topczewska, Katarzyna ;
Collin, Francois ;
Tarasiuk, Joanna ;
Czarnowska, Agata ;
Chorazy, Monika ;
Mironczuk, Anna ;
Kochanowicz, Jan ;
Kulakowska, Alina .
EUROPEAN NEUROLOGY, 2020, 83 (05) :487-492